The inherent complexity of drug development presents a wide range of challenges in the path to market. Successfully navigating from concept to commercialization calls on expertise and experience in order to reduce risk at every stage of production. A CDMO that consistently provides a supply of high quality, high purity, made-to-order compounds at the scale needed is one of the most valuable assets in today’s increasingly competitive market.
W. R. Grace’s (Grace’s) Fine Chemical Manufacturing Services (FCMS) has recently strengthened its already extensive portfolio of products and services by unifying its pharmaceutical development capabilities across North America. Through a breadth of facilities, resources, and experience, Grace’s FCMS can serve customers’ needs from coast to coast, ensuring supply chain efficiency, safety, and security throughout the product development journey.